A qualified provider at either platform can discuss how your medical history informs medication choice
Melanotan-I and -II" Pharmaceutical Biotechnology, 11:575-595 "Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study" Life Sciences, 58(20):1777-1784 "Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge" European Journal of Pharmacology, 660(1):88-93 "Targeting melanocortin receptors as a novel strategy to control inflammation" Pharmacological Reviews, 56(1):1-29 "Design of a new class of superpotent cyclic alpha-melanotropins based on quenched dynamic simulations" Journal of the American Chemical Society, 111(9):3413-3416 Produkt jest surowcem chemicznym przeznaczonym wycznie do zastosowa badawczych, naukowych i analitycznych in vitro
Shaking can denature the peptide and reduce potency
Antioxid Redox Signal 7(78):10531061 Fujiwara T, Dohi T, Maan ZN, Rustad KC, Kwon SH, Padmanabhan J, Whittam AJ, Suga H, Duscher D, Rodrigues M (2019) Age-associated intracellular superoxide dismutase deficiency potentiates dermal fibroblast dysfunction during wound healing
